# Eikon Therapeutics

**Canonical:** https://apis.io/providers/eikon-therapeutics/  
**Website:** https://www.eikontx.com  
**APIs profiled:** 0

Eikon Therapeutics is a biopharmaceutical company (Nasdaq: EIKN) founded in 2019 and headquartered in Millbrae, California, with additional offices in New York and Jersey City. Eikon built a proprietary drug-discovery platform around single-molecule live-cell imaging, applying super-resolution fluorescence microscopy and high-throughput single-molecule tracking to observe how proteins and drug targets move and interact inside living cells in real time. The technology descends from co-founder Eric Betzig's Nobel Prize-winning work in super-resolution microscopy, and the company is led by former Merck R&D chief Roger Perlmutter. Eikon uses these measurements to discover and develop novel therapeutics across oncology and other disease areas. This profile was surfaced as a portfolio company of Lux Capital and enriched by the API Evangelist pipeline; Eikon publishes a corporate and investor web presence but no public developer API, SDK, or machine-readable API surface at this time.

## Kin Score — 6.2 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 6.2).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 10.5 |
| Access Clarity | 10.5 |

Regulatory layer — **Health**: 12.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Eikon Therapeutics Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Biotech, Biopharmaceutical, Drug Discovery, Live-Cell Imaging, Super-Resolution Microscopy, Oncology, Life Sciences

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/eikon-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.